Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors

International Journal of Pancreatology

Volumn 26, Issue 2, 1999, Pages 69-76

  Koshiba, Takatomo ^a   Hosotani, Ryo ^a   Miyamoto, Yoshiharu ^a   Wada, Michihiko ^a   Lee, Jeon Uk ^a   Fujimoto, Koji ^a   Tsuji, Shoichiro ^a   Nakajima, Sanae ^a   Doi, Ryuichiro ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cox 2; Immunoblot analysis; Immunohistochemistry; Intraductal papillary mucinous tumor; Pancreatic cancer

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0032704323     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02781733     Document Type: Article

References (21)

1. 1 Thun MJ, Namboodiri MM, Heath CWJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-1596.
2. 2 Thun MJ. NAID use and decresed risk of gastrointestinal cancers. Gastroenterol Clin North Am 1996; 25: 333-348.
3. 3 DuBois RN, Giardiello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am 1996; 25: 773-791.
4. 4 Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-639.
5. 5 Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano RNP, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1991; 328: 1313-1316.
6. 6 Spagnesi MT, Tonelli F, Dolara P, Caderni G, Valanzano R, Anastasi A, et al. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterolgy 1994; 106: 362-366
7. 7 Williams CW, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 1996; 270: G393-G400.
8. 8 Coffey RJ, Hawkey CJ, Damstrup L, Graves DR, Daniel VC, Dempsey PJ, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 1997; 94: 657-662.
9. 9 Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
10. 10 Kargman SL, O'Neill GP, Vickers PJ, Evance JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 2556-2559.
11. 11 Ristmäski A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276-1280.
12. 12 DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996; 110: 1259-1262.
13. 13 Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987; 47: 5340-5346.
14. 14 Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809.
15. 15 Tsujii, M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340.
16. 16 Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 1996; 56: 5125-5127.
17. 17 Creminon C, Habib A, Maclouf J, Pradelles P, Grassi J, Frobert Y. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim Biophys Acta 1995; 1254: 341-348.
18. 18 Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, et al. Expression of two angiogenic factors vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer and its relation to angiogenesis. Euro J Can, 1998; 34: 1439-1447.
19. 19 Koshiba T, Hosotani R, Wada M, Lee JU, Fujimoto K, Miyamoto Y, et al. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic cancer. Cancer 1998; 94: 3336-3340.
20. 20 Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc 1982; 20: 348-351.
21. 21 Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, et al. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1990; 11: 393-395.